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Omitted doses are among the most common errors of medication errors in hospital. It is 
a need to identify the frequency of omitted doses and reasons for these to try to prevent 
them in the future.  It is important to ensure all medication is available on the ward when 
needed  and  this  can  be  evaluated  by  looking  at  different  medicines  management 
systems. 
Aim and objectives
To identify recorded reasons for dosing omissions and evaluate the clinical significance 
of  the  omissions  at  individual  patient  level  using  an  expert  group  of  four  clinical 
pharmacists.  Describe the different medicines management systems by using process 
maps and compare the findings. 
Methods
Reasons for dose omissions were recorded for several weeks in three different wards. 
Patients that had omissions recorded as Unavailable medicine were asked to take part 
in the study, and the clinical significance of these omissions was evaluated by an expert 
group. A suggestion for a guideline for nurses on what medicines that not should be 
omitted was developed by using results from this expert group meeting. 
Results
A comparison  of  the  three  wards showed  no  significant  differences  in  numbers  of 
unavailable medicines,  but  other reasons turned out to be different.  Of 74 cases of 
omissions presented to an expert group 21 was evaluated to category 2; Medicines that 
could cause major disturbance in symptom control and one in category 3; Major treat to 
stability of patients condition.
Conclusion
Omissions occur in different settings and can cause potential harm for patients. It  is 
important to ensure that all medication is on ward when needed to avoid these types of 
omissions. The study identified that it is room for improvement in all three wards, but 
more and longer studies need to be carried out to be more conclusive in which changes 
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1 Introduction
1.1    The National Health Service in UK  
The National Health Service (NHS) is the name commonly used to refer to the four pub-
licly funded healthcare systems in the United Kingdom, only the Health Service in Eng-
land uses the name “National  Health  System”  without  further qualification.  Since its 
launch 60 years ago, the NHS has grown to become the world’s largest publicly funded 
health service.
 When the NHS was launched in 1948 it had a budget of £437 million (roughly £9 billion 
at today’s value). In 2007/8 it received 10 times that amount - more than £90 billion. 
Some 60% of the NHS budget is used to pay staff. A further 20% pays for drugs and 
other supplies, with the remaining 20% split between buildings, equipment and training 
costs on the one hand and medical equipment, catering and cleaning on the other.  
Nearly 80% of the total budget is distributed by local trusts in line with the particular 
health priorities in their areas1.
The Department of Health (DH) is in overall charge of the NHS with a cabinet minister 
reporting as secretary of state for health to the prime minister.  The department has 
control  of  England’s 10 Strategic Health Authorities (SHAs),  which oversee all  NHS 
activities in England. The devolved administrations of Scotland, Wales, and Northern 
Ireland run their local NHS services separately1.
NHS is divided into two sections: primary and secondary care. Primary care is generally 
regarded as a “frontline” service. It is the first point of contact for most people and is 
delivered  by  a  wide  range  of  independent  contractors  such  as  GPs,  dentists, 
pharmacists and optometrists. Secondary care is known as acute health care and can 
be  either  elective  care  or  emergency  care.  Elective  care  means  planned  specialist 
medical care or surgery, usually following referral from a primary or community health 




In 2006 the NHS in Scotland had around 158 000 staff,  including more than 47,500 
nurses,  midwives  and  health  visitors  and  over  3,800 consultant.  Health  services  in 
Scotland  are  delivered  through  14  regional  NHS  Boards.  These  boards  provide 
strategic leadership and performance management for the entire local NHS system in 
their  areas  and  ensure  that  services  are  delivered  effectively  and  efficiently.  NHS 
Boards are responsible for the provision and management of the whole range of health 
services in an area including Hospital and General Practice3.
Scotland has in addition a further 8 special Boards; NHS National Services Scotland, 
Scottish Ambulance Service, NHS24, The State hospital, NHS Health Scotland, NHS 
Quality Improvement Scotland, NHS Education for Scotland and National Waiting Times 
Centre Board3. 
 
1.2 Medication incidents and the situation in the UK today
Every day, about two and a half million medicines are prescribed in the community and 
in hospitals across the UK4. Most medicines are used safely and help people to get 
better or stay well. The number of prescribed medicines has increased the last years, 
and following the NHS’ expenditure on medicines. Due to this it would be important to 
have focus on patient safety. 
Patient safety is recognised as a priority for healthcare organisations and is the first 
domain in the  NHS standards for better health.  Improving quality of care and patient 
safety has always been at the heart of the Government’s strategy for the NHS. 
The  National  Patient  Safety  Agency,  established  in  2001,  has  the  responsibility  of 
improving  the  safety  and  quality  of  patient  care  through  reporting,  analysing,  and 
disseminating the lessons of adverse events and ‘near misses’ involving NHS patients. 
Medication errors  occur  when  human and system factors interact  with  the  complex 
process of prescribing, dispensing and administering drugs to produce an unintended 
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and potentially harmful outcome. Awareness of the causes of medication errors and 
how they can be prevented has been growing in the NHS in recent years5
The publication of An Organisation with a Memory, the commitment by Government to 
the aim of a 40% reduction in serious error rates and establishment of the NPSA have, 
for the first time, provided a systematic focus on medication safety in the NHS.
Medication errors occur in all health care systems. Improving safety in the prescribing, 
dispensing and administration of medicines is a priority for health services in Europe, 
North America, Australia and many other countries. The Government has set out, for 
the first time, a clear agenda for improving patient safety in the NHS in England with, as 
a key element, the aim of a 40% reduction in the incidence of serious medication errors. 
This is the first truly national patient safety strategy to be developed anywhere in the 
world5
There is a need for safer use of medicines to get better and more convenient care. 
Different reports from the last years have focus on this; the safer use of medicines. One 
of  them is  the  fourth  report  from the  Patient  Safety  Observatory;  Safety  in  doses: 
Medication Safety Incidents in the NHS. It was published in 2007 and  brings into the 
public arena nearly 60,000 safety incidents reported by staff up to June 2006, as well as 
litigation and negligence data. The report describes the types of medication incident that 
can be prevented and includes examples of severe harm to patients. It also identifies 
seven  priority  actions  for  healthcare  staff,  NHS  Organisations  and  healthcare 
commissioners.  There  are  three  general  recommendations  and  four  relating  to 
particular risks that accounted for 65 per cent of all medication incidents reported to the 
NRLS4
Seven key actions to improve medication safety4:
1. Increase reporting and learning from medication incidents
Increase reporting and learning from medication incidents and identify actions against 
local risks in an annual medication report.
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2. Implement NPSA safer medication practice recommendations
Implement and audit the NPSA safer medication practice recommendations, including 
the alerts on anticoagulants, injectable medicines and wrong route errors published in 
March 2007.
3. Improve staff skills and competences
Healthcare workers should ensure they have the required work competences and sup-
port to use medicines safely. Work competences for anticoagulant therapy, use of in-
jectable medicines and paediatric infusions are set out in the NPSA safe medication 
practice work programme for 2007-08.
4. Minimise dosing errors
Provide information, training and tools for staff to make calculations of doses easier, 
and target efforts towards high-risk areas (such as children) and high-risk drugs (such 
as insulin).
5. Ensure medicines are not omitted
Identify current levels of omitted medicines and target areas for action (for instance, an-
ticoagulation or other high risk medication). Review medicine storage and medication 
supply chains.
6. Ensure the correct medicines are given to the correct patients
Improve packaging and labelling of medicines and support local systems that make it 
harder for staff to select wrong medicines or give medicines to wrong patients.
7. Document patients’ medicine allergy status
Improve recording of patient allergies, and raise awareness amongst staff of high-risk 
products and the importance of knowing the patient’s allergy status. 
1.3 Medication errors in hospitals
The Department of Health (DoH) has defined a medication error as ‘any preventable 
event that may cause or lead to inappropriate medication use or patient harm’.
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Recent  UK studies have suggested that up to 6.5 per cent of all patients admitted to 
hospital  and  up  to  nine  per  cent  of  all  patients  staying  in  hospital  experience 
medication-related harm. The three most frequently occurring types of medication error 
(wrong dose, strength or frequency of medicine, omitted medicine and wrong medicine) 
accounted for over half of all reported medication incidents (57.3 per cent). Of these, 
the most common type of error was wrong dose, strength or frequency of medication 
(28.7 per cent) 4.
The DoH’s report “An Organisation with a Memory”, found that 10,000 hospitals patients 
each year have serious adverse effects to medicines, and one-fifth of clinical negligence 
litigation stems from hospital medication errors. 10.8 per cent of patients on medical 
wards  experience  an  adverse  event,  46  per  cent  of  which  were  judged  to  be 
preventable6.
Up to 38% of inpatient medication errors occur at the administration stage7. In hospitals 
there are often seen that single doses are omitted and there is many reasons for this, 
such as patients refusing to take the dose or that they are unable swallow the medicine. 
Another important reason is unavailable medicines; the item is not on the ward and 
must be ordered from pharmacy before it can be administered. Communication between 




“Safety in doses: medication safety incidents in the NHS” reported that omitted medi-
cines were the second most commonly reported type of medication incident in hospitals. 
An omission is not always considered as a serious error but the National Reporting and 
Learning System (NRLS) data included reports of permanent harm or death where vital 
medicines (for instance, medicines used to treat epilepsy or prevent strokes) had been 
omitted4.
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There could be many different reasons for omitted medicines; medicines not prescribed, 
not dispensed or not administered to the patient. As mentioned earlier a lot of medica-
tion errors occur at the administration stage, and often this includes omitted medicines. 
Sometimes the medicine are withheld or discontinued by doctor with good medical/clin-
ical reasons. But very often other reasons are charted such as the patient refused to 
take the medicine or was unable to swallow, patient not on ward or unavailable medi-
cine. Many omitted doses can be prevented for example by using alternative routes for 
the patients that can’t swallow, and the nurses could make sure that every medicine 
needed is on the ward before starting medicine round.  
1.3.1.1 Clinical significance of dosing omissions
Missed doses are medication errors and by definition, they are avoidable.  The impact 
on individual patients varies depending on the drug and the clinical situation, where the 
consequences can range from no harm to death8.  
In most cases, short term medication omissions are unlikely to cause harm to patients. 
However,  for  patients  who  rely  on  taking  medicines  regularly  to  stay well,  such as 
people with diabetes, epilepsy or transplants, missed doses may result in severe harm. 
Similarly,  for  patients  who  are  acutely  unwell  and require  immediate  treatment,  the 
omission  of  a  medicine,  for  example,  intravenous  antibiotics  over  a  weekend,  may 
cause harm. In addition age, sex of patient and other medicines prescribed could have 
an importance in the evaluation of clinical significance of the dose omission. 
It is always important that patients get their medicine, but if the medicine is prescribed 
once daily, it is more important not to miss that dose, than if the medicine is prescribed 
for  several  times  during  the  day. Omitting  three  consecutive  doses  of  the  8-hourly 
regimen does not produce as low a concentration as the omission of single daily doses9. 
1.3.1.2 Studies of omitted doses in the UK
Several  studies  have  been  done  on  omitted  doses  in  the  UK,  and  the  clinical 
significance has been evaluated. In Dowling’s study “Missed doses audit” around 14 
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reasons for omitted doses were recorded and in total there was 714 missed doses. Out 
of these 182 were classified as high risk missed doses, and the largest drug class were 
cardiac medication and antibiotics. The missed doses that were considered  to be low 
risk included mainly senna, lactulose, paracetamol and co – codamol. Dowling wrote 
that it was difficult to define a high risk drug without knowing the indication for its use; 
this was not recorded in this audit10.
Another study “Aetiology of Omitted Medication Doses at Kings College Hospital NHS 
Foundation  Trust”  was  done by the  Pharmacy Department,  King’s  College Hospital 
Foundation Trust, London (Garcia M). Twenty-two of the forty-four wards in the hospital 
were selected. These represented all the specialties within the hospital and were the 
same wards used to assess other clinical pharmacy quality indicators. On each ward, 
the total  number of  regular doses prescribed and omitted on all  drug charts,  in the 
previous 24 hours was counted for each patient. The majority of doses were omitted for 
clinical reasons (Category D - 72.9%, 345 doses). 6.1% (29) of omitted doses were due 
to unavailability outside pharmacy working hours (category C) and 3.6% (17 doses) 
were omitted because of unavailability during pharmacy working hours11.
A similar study was done by Dhruti Bhatt, “Audit of Dose omission and completed drug 
allergy status”. The author investigated what percentage of doses that were omitted in 
three  hospitals  Highgate  Mental  Health  Centre,  St  Pancras  Hospital  and  St  Lukes 
hospital.  All dose omissions were obtained from patients’ drug charts across a five day 
period. In total 37 % of all doses were omitted (the three hospitals had 23%, 22% and 
69 %). Patient not available counted for 60 % of the dose omissions, followed by patient 
refusal (24 %). The third biggest reason was unavailable medicine12. 
Some of the numbers found in these studies are unacceptable high, and there is a need 
to focus on this. The supply systems need to be reviewed where unavailable medicines 
are a big problem, and information on the importance of administrating single doses 
should  be  given  to  the  nurses,  as  well  as  the  patients.  One  of  the  seven  keys  to 
patients’ safety in NHS report is to ensure medicines are not omitted, and with more 
studies done and more information on this area the number of missed doses should 
decrease.
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1.4 Medicine management systems in the UK 
1.4.1 Medicines management –definition and categorisation
Managing  medicines  safely  is  a  key  component  of  the  NHS  Standards  of  better 
health4,13.
There are several definitions of MM systems. Medicines and healthcare products regu-
latory agency (MHRA) has defined managing medicines as: The clinical, cost effective 
and safe use of medicines to ensure patients get the maximum benefit from the medi-
cines they need, while at the same time minimising potential harm.14
Medicines management in hospitals encompasses the entire way that medicines are 
selected, procured, delivered, prescribed, administered and reviewed to optimise the 
contribution  that  medicines  make  to  producing  informed  and  desired  outcomes  of 
patient care6.  Medicines management services provide patient focused care based on 
need. They can include all aspects of supply and use of medicines, from an individual 
patient level to an organisational level15. 
A survey carried out by the National Prescribing Centre (NPC) in 2001 together with 
other work done in the area of medicines management, led to the classification of such 
services into five main types15:
1. Clinical medicines management
Clinical medicines management services involve assessment, monitoring and 
review of prescribing for individuals.
2. Systems and processes
Improving repeat prescribing, ensuring that guidance and policies are implemented, and 
undertaking audits are all part of medicines management.
3. Health of the public
Medicines management services appear in their broadest sense when they are included 
in schemes that address public health and provide education about medicines.
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4. Medicines management at the interface
Systems and communication often break down at the interface between health care 
settings leading to poor patient care. Examples of services include use of formularies 
and guidelines, discharge planning and the use of patients’ own drugs in hospital. 
5. Patients and their medicines
Integration  of  health  and  social  care  is  an  important  part  of  current  NHS reforms. 
Medicines management services could help bring together
1.4.2 Self administration of medicines (SAM)
Self administration of medicines is a programme where patients have responsibility to 
manage and administer their own medicines whilst in hospital. This is thought to have 
many benefits such as improving patient knowledge and compliance with their medica-
tion and increasing patient empowerment and rehabilitation. Medication timing can be 
more accurate and medicines management  problems can be indentified before dis-
charge, making this a speedier process. There is a new trust policy for self administra-
tion of medicines which states that practitioners should assess all patients on the ward 
with the ‘SAM quick step check’ and the patients meeting these criteria should be fully 
assessed to determine their level of SAM. Level 1 is when the practitioner educates the 
patient whilst administering the medicines, level 2 is where the patient takes their medi-
cines under supervision but the practitioner retains responsibility for storage and secur-
ity and level 3 is when the patient administers their medicines themselves and is also 
responsible for storage and security16.
A recent study was done to assess the potential impact the new trust policy will have on 
medical, surgical and elderly wards by assessing the number of patients suitable for self 
administration, and to estimate the time taken for the assessments. Of 156 patients as-
sessed in total, 53 (34 %) were likely to be self administering on discharge, and were 
suitable for the full assessment. Of this one patient was at level 1, six patients were at 
level 2 and seven patients were assessed to be at level 316. 
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Combining SAM with reuse of patients’ own drugs mean patients can continue to use 
medicines they are familiar with during their hospital stay. The benefit of SAM is that pa-
tients maintain control of their medicines. Any changes in treatment while in hospital can 
be  discussed and implemented with  each patient’s  involvement.  It  also  means that 
when patients are discharged from hospital, they are informed to their treatment and are 
much more likely to take their medicines as intended17.
The study “Are patients who self-administer their medicines in hospital more satisfied 
with their care?” surveys patients’ views on self-administration and on their care. In par-
ticular it looks at the discharge process and the way information was given to the patient 
on discharge. The study found that  a majority of  patients  under  60-years-old would 
choose to self-administer their medicines in hospital even if they had not been given the 
opportunity to do so recently. It was also found that patients who had administered their 
own medicines in hospital were more likely to report their overall care as excellent and 
were more satisfied with the discharge process than patients who had not18.
1.4.3 JAC Computer Services
JAC Computer Services Ltd (JAC) is the leading supplier of medicines management 
solutions to the NHS.  JAC's UK user-base now accounts for around half of all  NHS 
trusts in England as well as sites in Scotland, Wales and Northern Ireland. JAC provides 
pharmacy  stock  control,  e-prescribing  and  medicines  administration  as  a  single 
integrated solution along with associated services and third-party interfaces. JAC is also 
the  exclusive  distributor  in  the  UK and  Ireland  of  ServeRx  ward-based  automation 
technologies for medicines and medical equipment. 
The  JAC  solution  for  ePrescribing  and  Medicines  Administration  (EPMA)  includes 
integrated in-patient and out-patient prescribing, discharge prescribing, decision support 
for providing warnings on allergies, drug-drug interactions and therapeutic duplicates, 
as well as bed-side medicines administration support and recording. In May 1996, JAC 
was acquired by Mediware Inc and continues to operate as a wholly owned subsidiary. 
The  acquisition  by  Mediware  Inc  created  the  world's  largest  supplier  of  medicines 
management systems for hospital pharmacies19.
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1.5 Medicines management at Ayr hospital 
Ayr hospital has three different medicines management systems;  redesign system (at 
ward  10  and  14),  a  pilot  at  ward  16  using  reports  from  HEPMA  system  and  the 
traditional top-up (on all remaining wards)
1.5.1 Redesigned  system
For the patient journey to be successful there is a requirement to minimise delays and 
provide continuity of care. Thus removing unnecessary steps and to involve patients 
more in their own care and treatment. As a part of the redesign process, a scheme that 
encompasses one-step dispensing (OSD) with the re-use of patient’s own drugs (PODs) 
has been implemented in the hospitals in NHS Ayrshire and Arran20. All wards with this 
system have been supplied with bedside lockers which include a POD locker.  Each 
patient’s PODs are stored in their bedside lockers but painkillers, antibiotics, lactulose 
and nebules are not stored here.
The concept of using PODs during a patients hospital stay was first introduced by the 
report ‘A Spoonful of Sugar’. The audit highlighted that by introducing a POD system the 
cost of medicines to be supplied during a patients hospital stay could be reduced and 
the incidence of missed medication doses would also be reduced21.
It makes sense to use the patient’s own supply during their hospital stay and also at 
discharge. One-stop dispensing is dispensing only once for the patient during a single 
hospital admission. All the medications for each individual patient, where possible, are 
dispensed in original pack(s), include a patient information leaflet and labelled with the 
full instructions. This is provided in a sufficient quantity to allow the patient to take the 
same supply home on discharge. 
Admissions can be divided into two- arranged and emergency admissions. All patients 
that have arranged admissions are asked to bring in their own medications to hospital. 
Some patients are seen by a pharmacist at pre-op clinic and these patients will receive 
an  explanation  of  the  medicines  redesign  system.  Arranged admission  patients  are 
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receiving  a  leaflet  “using  your  medicines  during  your  hospital  stay”  with  their 
appointment. The patients are given a green POD bag to have their own medication in 
at admission. Before any PODs can be used in hospital they must be assessed for 
suitability and any POD trained pharmacy technician or nurse can do this. 
Every day a technician is  on the ward  with  a  list  over  new patient  that  have been 
arriving the last day. It is checked what these new patients have been prescribed and if 
the pharmacist has verified the drug list. The technician takes the medications which are 
a stock item from the ward cupboard. If there are some medicines which are non-stock 
items the technicians order this from the pharmacy, and minutes after it comes with the 
tube system. After this the medications are labelled and put in patients’ bedside locker, 
a locker beside every bed. Medicines called PRN is drugs the patients can have when 
required,  for  example painkillers.  If  any patients  need something of  PRN medicines 
when they are going home, this is prescribed at discharge. 
It’s a lot of benefits with the redesign system with OSD/PODs. Because the patients 
have their own medicines with them and these are kept in the patient’s bedside locker, 
the  chance  to  get  another  patient’s  medicines  is  being  reduced.  Also  the  risk  of 
medication  errors,  duplications  or  omissions  is  reduced.  Because  of  the  one-stop 
dispensing there will  be faster discharges from hospital as there will be fewer delays 
waiting for discharge medication. In addition clinical pharmacists will be able to spend 
more time with  patients  and the nursing staff  will  get  an improved relationship with 
pharmacy staff.
One other important benefit of the system is less wastage of medicines and a reduction 
in overall expenditure of medicines. 
1.5.2 HEPMA (Hospital Electronic Prescribing and Medicines Administration)
The Station 16 Pilot Proposal was started on Monday 15th September 2008. The pilot 
involved utilising IT information from the JAC prescribing system to identify non stock 
medicines prescribed. The non stock medicine is issued and labelled for the individual 
patient and kept in the medicine storage area of patient locker. Stock item medicines 
used ward  cupboard  stock.  The indication  is  that  the  pilot  system is  equally  if  not 
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potentially more time efficient than the current system22. The staff involved in supporting 
the pilot considers this system is suitable to expand to other wards within Ayr Hospital 
and would be the standard process for the supply of medicines. 
There are three options to proceed in the near future and the recommendation is to use 
option 3; Option 3 – expand the station 16 pilot to all wards within Ayr hospital. After the 
medicine supply system is established in all wards the plan would be to revisit each 
ward following the initial implementation route to expand the process to utilise non-stock 
medicines for discharge where appropriate. 
The results from the first 4 week before the pilot show that the number of medicines 
charted as unavailable was 143. During the pilot the number of medicines charted as 
unavailable was 68 of which 54 % was at 10 pm, this was usually due to late patient 
transfers into Station 16.  In  the last  week of the pilot  there were 21 missed doses 
compared to 48 the same week in the 4 week period before the pilot23.
The system in practice
- Patients get prescribed medicines on JAC-electronic prescribing. 8am dose is not 
written as unavailable until 9.30 am. The technician checks of bedside locker for 
non stock medicines first and stock trolley for ward stock medicines. 
- Pharmacy review new non stock items prescribed report 3 times every day, at 
8am, 12.45pm and 03.00pm. Non-stock medicines are dispensed for individual 
patient, bagged and sent via tube or porter. Non-stock medicines that no longer 
are prescribed are bagged, identified and returned to pharmacy.
- Pharmacy also review a list printed 3 times daily including all medicines charted 
as unavailable since the last report
- Pharmacy monitor eye drops, insulin, non stock oral antibiotics and IVs. Every 
Wednesday a technician monitors and reviews further supplies for patients with 
longer than 14 days stay. Ward stock is topped up twice weekly. 
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- Because this is a pilot they are not aloud to use the same medicine boxes at 
discharge. 
1.5.3 The traditional top-up
The  traditional  top-up  system  is  used  on  most  of  the  hospital  wards.  Pharmacy 
technicians top up the stock cupboards twice a week, and check ward trolley once a 
week. If any medicines are needed, these are ordered by a nurse and sent via tube 
system or via porter. 
1.6 Electronic prescribing
Traditionally, for patients staying in hospital, doctors wrote a prescription by hand. This 
was taken to the hospital’s pharmacy and a number of staff were involved in preparing 
and checking the medication before ward staff collected it and finally administered it. An 
electronic prescription can now be with the pharmacy immediately; pharmacy staff then 
prepares the medication more quickly – and this speeds up the patient’s treatment24.
The main aim of electronic prescribing systems is to reduce medication errors (incorrect 
dosages, a drug-drug interactions or drug-allergy interactions etc.) and adverse drug 
events (ADEs - problems that result from medication errors) and consequently improve 
standards in patient safety25.
An electronic prescribing system could improve patient safety by reducing prescribing 
and  administration  errors  that  could  result  in  medication  errors  and  adverse  drug 
events. At its simplest level, E-Prescribing can be defined as “the utilisation of electronic 
systems  to  facilitate  and enhance the  communication  of  a  prescription  or  medicine 
order, aiding the choice, administration and supply of a medicine through information 
and decision support  and providing a robust audit  trail  for  the entire medicines use 
process”26.
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1.6.1 Electronic prescribing in the UK
There are several studies that demonstrate that an EPA system can improve the quality 
of prescription writing and reduce medication errors compared with a paper system. 
An audit done by Andrew Barker and Julie Kay concludes with the following; Electronic 
prescribing improves patient safety27.
A study done in 2007 showed that electronic prescribing significantly increased quality 
in  a  UK  hospital,  this  was  shown  by  fewer  pharmacists’  interventions  and  fewer 
prescribing errors. Interventions were reduced from 73 (3.0 % of all medication orders) 
to 45 (1.9 %) (95 % confidence interval  for the absolute reduction 0.2, 2.0 %), and 
errors from 94 (3.8 %) to 48 (2.0 %) (95 % confidence interval 0.9%, 2.7%)28.
1.6.2 Electronic prescribing at the Ayr hospital
An extended trial of electronic prescribing and administration (EPA) began in six wards 
at  Ayr  Hospital,  Ayrshire  and  Arran  Acute  Hospitals  NHS Trust,  in  Nov 2001.  The 
extension of EPA followed a small-scale trial of a similar system which started in 1998 
and  demonstrated  that  an  EPA  system  reduced  medications  errors  and  improved 
quality  of  prescription  writing.  After  three  years  co-operation  with  the  company that 
produced the software, JAC, the new EPA system was introduced over a three week 
period adding two wards per week29.
Ayr Hospital is the only hospital in Scotland which has a fully computerised electronic 
prescribing and medicines administration system (EPMA). The Association of Scottish 
Trust Chief Pharmacists presented a conference on electronic prescribing in Stirling on 
1st November  2000-11-03.  The  conference  was  aimed  at  increasing  the  level  of 
understanding  of  the  issues around electronic  prescribing  in  health professionals  in 
Scotland.  The  evaluation  of  the  electronic  prescribing  pilot  at  Ayr  hospital  was 
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presented and it showed that the electronic prescribing and administration system was 
as  least  as  safe  as  the  previous  paper  based  system  and  that  the  incidence  of 
medication errors was reduced in most types of error30. 
1.7 Process maps
A process map is a flow chart where actions are represented by different symbols; each 
symbol contains one step of the total process. The process map describes the process 
as it is performed most of the time, but differences from it can occur. 
Process  mapping  is  designed  to  provide  a  framework  for  developing,  testing  and 
implementing  changes  that  lead  to  improvement.  The  core  benefit  of  any  process 
mapping exercise is improved efficiency.  This can largely be expressed in  terms of 
operational  cost  savings,  such  as  time  saved,  better  use  of  available  resources, 
improved communications between departments, ultimately less frustration and a more 
effective service for carers and patients alike. Any current process can be analysed to 
investigate if changes could make efficiency gains31.
As a part of the ongoing efforts of the Modernisation Agency and the continued focus on 
constructing a better  NHS built  around the people it  serves,  process mapping is an 
effective  and  proven  method  of  developing  changes  that  can  really  start  to  make 
difference31.
1.8 Clinical setting
Station 16 Geriatric ward
Elderly  people  are  admitted  to  this  station.  From this  ward  the  patients  either  get 
discharged to another hospital,  to a nursing home or they are deceased. The ward 
includes around 22 beds and 3-4 patients are admitted to the ward every day. This is 
also a ward with stroke patients. Every day around 11 o’clock a doctor, a chief nurse 
and a pharmacist are doing a ward round, checking every patient and prescribe new 
medication. 
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Station 14 – Medical ward
Station 14 is a general medical ward where patients are admitted with all different kinds 
of complaints. The ward has 30 beds which normally are occupied all  the time, and 
around  5  new  patients  are  admitted  to  the  ward  every  day.  The  ward  has  a 
rheumatologist, two endocrinologists and one doctor with speciality in care of elderly 
people. In addition two pharmacists are at the ward for several hours during the day. 
This ward has the redesigned system for medicines management which includes using 
patients own drugs and one stop dispensing. 
Station 6 – Cardiology ward
Station 6 is a general medical and cardiology ward with 24 beds. Normally all beds are 
occupied and about 3 new patients are admitted to the ward daily.  This ward has the 
traditional top up system for supply of medicines. 
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2 The project – aim and objectives and setting
2.1 Aim
The aim of the project is to compare three medicines management systems in medical 
patients in terms of; (1) the nature and the incidence of medicines dose omissions; and 
(2) the relative safety risk from assessment of clinical impact of the omissions
2.2 Objectives
1. Review the NHS literature on risks to patient safety of errors in medication use 
and on hospital medicines management systems
2. Interrogate the HEPMA system prospectively to identify recorded reasons for a 
dose  omission.  Dose  omissions  recorded  as  ‘Unavailable  Medicine’  will  be 
confirmed  from  inspection  of  the  medicines  room  or  talking  to  a  pharmacy 
technician. 
3. Design  a  template  to  summarise  anonymously  the  clinical  context  for  each 
patient that is the subject of an ‘Unavailable Medicine’. 
4. Evaluate the clinical significance of the subset of dose omissions at individual 
patient level, using an expert group of four clinical pharmacists 
5. Describe  in  detail  using  a  process  map  (flow  diagram)  the  three  medicines 
management systems and compare the findings.
6. Develop guidelines to help inform ward staff about medicines that should not be 
omitted.  Validate  the  guidelines  through  group  interview  with  pharmacy  and 
nursing staff.  
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2.3 Setting
The study was carried out on three wards with different medicines management system 
at Ayr hospital. A data collection on a general medical ward (ward 14), a geriatric ward 
(ward 16) and a cardiology ward (ward 6) was done for two weeks on each ward in 
January to March (and a week in april).  
30
3   Methods
All three researchers at Ayr  hospital were introduced to the different systems at the 
hospital. The researcher was following different pharmacists around at several wards 
and was introduced to the electronic prescribing system and the pharmaceutical care 
plan used at  the hospital.  Station 7,  acute medical  receiving ward  and the medical 
wards station 6 and 14 were visited. 
3.1 Ethical approval 
A short summary of the project including introduction, aim, objectives and methods was 
written  in  December,  and  sent  to ethics  committee  with  a  request  if  approval  was 
needed. They replied in January with an answer that ethical wasn’t needed and the data 
collection and including of patients could start. 
3.2 Literature review
The literature was obtained from research in different electronic library databases such 
as  PubMed,  and  from  accessing  other  relevant  NHS  documents  locally  and  from 
standard operating procedures at Ayr hospital.   Some research was done via different 
internet  engines as well,  such as Google,  when the other  sources mentioned were 
insufficient. 
The investigator visited some of the wards at the hospital to find out if the nurses have 
any  written  procedures  (standard  operating  procedures)  about  administration  of 
medicines. A standard operating procedure written in 1996 was the only one found; no 
updated version about administration of  medicines was on the hospital.  The nurses 
used  standard  guidelines  on  managing  medicines  (from  the  Nurse  and  Midwifery 




After having the project summary from University there was focused on the different 
medicine management systems on Ayr hospital. EJ and KRL were introduced to the 
pilot on the HEPMA system at station 16 by a pharmacy technician, and both of the 
researchers visited a ward with the traditional top-up system and the redesign system. 
Information about how the different systems work in supplying medicines to the ward 
and  managing  medicines  in  general  was  given  by  pharmacy  technicians  on  these 
wards. The researcher also followed one technician on ward when doing top up of ward 
cupboard to see how this was done. 
 
In January templates were designed for recording the dosing omissions (See appendix 
1 and 2) Separate templates were made to collect all dose omissions during one day 
and the clinical context for each patient with a dose omission. The template had a part 
with patient information; a short summary of medical history, current drugs and present 
complaints. The other part contained recorded dose omissions, and time and date of 
the omission. The template was made to summarize anonymously the clinical context 
for each patient to enable the expert group to evaluate the clinical significance of the 
dose omission. Each template had patient number instead of patient name to keep it 
anonymously; the patient name was written down on a list and kept separate from the 
templates. 
All  templates  were  tested  several  times  at  ward  14.  Changes  made  in  one  of  the 
templates was followed up by more testing to make sure that they were  sufficient for 
using at data gathering. After testing the templates and getting used to the JAC system 
to find information about drug administration for each patient, the data collection and 
patient inclusion were started on 27th of January. The first two patients were included by 
pharmacist RM at the general medical ward (station 14). This was done to introduce the 
researcher to the methods of consenting patients, and to ensure right and appropriate 





A survey of omitted doses was conducted using the HEPMA system. Reasons for dose 
omissions were recorded at three wards with different medicines management systems 
for  several  weeks.  The  data  gathering  took  place  at  a  cardiology  ward,  a  general 
medical ward and a geriatric ward at the Ayr hospital for 2 weeks on each ward. 
A PAC (Patient Administration Chart)  on the computer system is an inquiry function 
detailing all administrations for a patient. All medication prescribed for a patient for a 
selected episode is listed. The medications are sorted in the same order as is currently 
being used for the Prescriber Order Entry (POE). Behind every drug there are white 
boxes for the different dates which are marked green when the doses are given. If the 
doses  for  any  reason  aren’t  given,  the  box  remains  white  and  the  reason  for  the 
omission is chosen by a nurse from a list of several reasons. The system forces the 
nurse to write a reason if  not administrated, the next dose of the medicine can’t be 
charted as given until the dose before is charted as given or a reason for not given. 
Table 1 Reasons for dose omissions the researcher chose to record in the study
- Absent from ward
- Fasting patient
- IV Access unavailable
- Refused
- Unable to swallow
- Unavailable medicines
- Withheld
Several  other  reasons  for  omitted  medicines  were  not  recorded  in  the  study,  for 
example administration discontinued, alternative route used, alternative administered 
and discontinued drug.  The investigator  chose to  record  omissions  from the  7  first 
reasons listed because these ones results in that the patient don’t get their medicine 
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and often these omissions can be prevented. Where “alternative route” or “alternative 
administered”  is  charted  as  reason  the  patient  actually  get  some  sort  of 
medication/treatment.  Other  reasons  that  weren’t  included  were  for  example 
discontinued drug,  administration discontinued or order  suspended.  Since these are 
resolutions made by a doctor and normally have a medical reason, they are not really 
omitted doses. 
Every  day  the  patients’  administration  charts  were  checked  for  omitted  doses. 
Administration of medicines at 6 pm and 10 pm were checked and written down the next 
morning. Information on the evening doses was obtained by checking a 24 hours PAC 
which shows all drugs administrated to the patient the last 24 hours. Every omitted drug 
in the 7 listed categories was written down to try to find out if any certain drug were 
omitted more often than others. 
3.4.2 Inclusion of patients
Every patient that had a medicine charted as “unavailable medicine” in the period of the 
data collection was asked to take part in the study. Because the researcher isn’t a part 
of the patients’ treatment group, consent is needed to use any information from medical 
notes about the patients’ medical history and present clinical conditions. (Health Rights 
Information Scotland)
The patients got a sheet of information about the study; why it was carried out, why they 
were asked to take part and possible benefits from taking part of it. If they agreed to 
take part in the study, they signed a ‘Consent Form’ (see Appendix 3 and 4 ). When this 
form was completed the patient had one copy and the researcher one. The original form 
was filed in the patient’s medical notes.  A nurse or a pharmacist on the ward was 
always asked if the patients were suitable to speak to the researcher about the study. 
Patients that were unable to or didn’t  want  to give consent were excluded from the 
study. Omissions from these patients were included in the recording of total omissions 
from each ward, but left out of the cases that were going to be presented to the expert 
group. 
34
After 2 weeks of data collection on each ward the researcher only had managed to 
include 25 patients in total. 46 % of the patients that had an “Unavailable Medicine”, and 
therefore  should  have  been  included  in  the  study,  were  not  able  to  speak  to  the 
researcher and sign the consent form. Most of these patients were not well enough or 
were  confused/had  dementia.  To  get  more  patients  included  another  period  with 
recruitment of patients was needed.
Another week on each ward in addition to the two first weeks of data gathering was 
done in the beginning of April. This time all the three wards were done at the same time 
and  only  unavailable  medicines  were  written  down;  all  the  other  reason  for  dose 
omissions were left out. This was done to get more time to speak to the patients, and try 
to avoid those patients that were well  enough to speak to the researcher, not were 
discharged before they had signed the consent form.
3.5 Expert group
All omitted drugs from the patients included were categorized after a system in British 
National Formulary (BNF) (Appendix 5)
There was made a summary of  the clinical  context  for  each patient included in the 
study.  Each context/summary was marked with patient number instead of name so it 
would be totally anonymous. Information about patients’ conditions and medical history 
were  obtained  by  reading  in  patient  journal,  acute  medicine  leaflet  and  the 
pharmaceutical care plan. An example of a case is presented in appendix
The  expert  group  consisted  of  4  pharmacists  from  different  medical  wards.  Two 
meetings were arranged, where the first one was to inform the pharmacists about the 
study and how to evaluate the clinical significance of each dose omission. Some cases 
needed more details to be evaluated, such as when the patients were admitted and 
results from blood tests. These details were added and a short meeting were arranged 
to evaluate the last cases. 
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The clinical significance of dose omissions was evaluated by a category system from 
0-4. The four pharmacists made a decision together about the clinical significance, and 
any different opinions were written down. 
0 No threat to patients care
1 Minor disturbance to symptom control 
2 Major disturbance to symptom control 
3 Major threat to stability of patients condition
4 Potentially able to precipitate a life threatening event
3.6 Developing guidelines
After the expert group had evaluated each omission, all in category 2 and 3 were written 
down as a summary for the nurses over medicines that should not be omitted. The 
guidelines were presented to some of the pharmacists from the expert group to check if 
something important were left out. 
3.7 Process mapping
To describe the three medicines management systems a process map (flow diagram) 
for each ward was made. The process maps contain how medicines are supplied on the 
different  wards  to  try  to  compare  and  identify  differences  in  the  three  systems. 
Information about the systems was obtained from reading documents on the systems 
and  by  asking  questions  to  pharmacy  technicians.  The  final  process  maps  were 




Relevant articles and reports about medication incidents and medication errors were 
found on different websites. The search engine ‘Google’ was also used sometimes to 
find relevant articles. Some standard operating procedures and guidelines were found 
on  the  hospital,  and  the  researcher  got  information  about  the  different  medicines 
managements  from pharmacy  staff.  This  included  nurse  training  documents  on  the 
Redesign system, information about the pilot on station 16 which are using information 
from the JAC prescribing system to identify non stock medicines prescribed and “Code 
of practice- Administration of Medicines”. 
4.2 Process maps
In this project a process map was made of each of the three medicines management 
systems at Ayr hospital. They were made to describe differences between the ways to 
supply medicines in the three wards. 
Table 2 Process map: Description of symbols





Represents the first and 
last step of process
Represents a step in a 
process (activity or task)
A question with a Yes or 
No answer
An arrow that connects 
the different boxes in 
the process map
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Patient admitted to 
hospital 
Patient already on 
ward
Did the patient 
bring own 
medicines?










































































* One stop dispensing: On admission pharmacy technician ensure that patients has at 
least 14 days of supply at discharge. 
Figure 1. Description of medicines management system – Redesigned system
38
Patient admitted to 
hospital
















Is the medicine 
in emergency 


















and supplied when 
pharmacy is open
Medicine is supplied 
from another hospital 

















List over non-stock 
item prescribed runs
 3 times daily in 
pharmacy
No
Patient admitted to 
hospital
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List over medicines 
charted as unavailable 
runs 3 times daily in 
pharmacy













Is it important to 
give the medicine 
this day?
No
Medicine is supplied 
from another 
hospital or from 
medicine factory
Yes
Figure 3.  Description of medicines management system - HEPMA
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4.3 Data collection of omitted doses
Numbers of omitted doses from all three wards are presented in tables (appendix 6). 
Ward 16, the geriatric ward had the highest percentage of omitted doses in the 2 weeks 
period the data collection was carried out. In total 489 doses of 4973 were omitted in 
the seven reasons which gives a per cent of 9.8 %. Ward 14 had 511/6165 (8.3 %) and 
Ward 6 331/4360 (7.6 %).
 For all three wards the reason for most of the omitted doses was the omitted doses 
charted as “Refused”. This reason made 205 of 4973 doses (4.1%) for  the geriatric 
ward,  247/6165 (4.0%) for  the  general  medical  ward  and 148/4360 (3.4 %) for  the 
medical cardiology ward. The reason that was observed to be charted second most was 
“Unable to swallow”. In ward 16 this reason was calculated to 150/4973 (3.0 %) of total 
doses available for administration. The third reason charted most were not the same on 
the  three  wards;  “Withheld”  was  the  reason  for  ward  6  and  16  and  “Unavailable 
medicine” for ward 14. 
The comparison of the distribution of  reasons of dose omissions was performed by 
using Fischer’s exact test. Fisher's test is the best choice as it always gives the exact P 
value, while the chi-square test only calculates an approximate P value. A p-value less 
than 0.06 shows a significant difference between two settings; the lower the p-value the 
more significant is the difference. 
When comparing three wards, two and two wards were compared with each other to 
say if there were any significant differences between the three wards. The comparisons 
between  the  three  settings  are  shown  in  tables  below.  Table  3  is  presenting  the 
frequency distribution of reasons for omissions and what they make out of total omitted 
doses. Table 4 is a comparison of the three wards based on numbers from table 3. 
P-values were calculated from Fischer’s exact test from 2x2 tables. 
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Table 3 Frequency Distribution of Reasons for Omissions Ward 14 (n=511), ward 16 (n= 
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Reason Ward 14/Ward 16 Ward 16/Ward 6 Ward 14/Ward 6
Absent from ward p = 1.000 p = 1.000 p = 1.000
Fasting patient p = 0.468 p < 0.001 p = 0.005
IV access 
unavailable
p = 0.085 p = 0.050 p < 0.748
Refused p = 0.031 p = 0.430 p < 0.257
Unable to swallow p < 0.001 p < 0.001 p < 0.001
Withheld p = 0.921 p < 0.001 p < 0.001
Unavailable p = 0.013 p = 0.009 p = 0.771
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A comparison of  the  three wards  shows that  numbers  of  several  reasons for  dose 
omissions are significant different. When comparing ward 14 with ward 16, the numbers 
of  refused,  unable to swallow and unavailable medicine were significant different from 
each  other.  The  comparison  between  ward  16  and  6  shows  significant  difference 
between all reasons except from refused and absent from ward. When comparing ward 
14 with ward 6 numbers were different for several reasons;  fasting patient, unable to 
swallow and withheld. 
Table 5 presents frequency distribution of reasons for omissions and what percentage 
they made out of total doses that should have been administered in the 2 weeks of data 
collection. Table 6 presents compares data for the three wards. 
Table 5.  Frequency Distribution of Reasons for Omissions n= 6165 for ward 14, n= 4973 
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* The numbers for ’Unavailable Medicine’ are from 3 weeks of data collection, and the total 
number of doses used is n= 9574 for ward 14, n= 7162 for ward 16 and n=6383 for ward 6.
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Reason Ward 14/Ward 16 Ward 16/Ward 6 Ward 14/Ward 6
Absent from ward p = 0.879 p = 1.000 p = 0.805
Fasting patient p = 0.902 p = 0.010 p = 0.017
IV access 
unavailable
p = 0.045 p = 0.015 p < 0.679
Refused p = 0.795 p = 0.073 p < 0.115
Unable to swallow p < 0.001 p < 0.001 p < 0.001
Withheld p = 0.434 p < 0.001 p < 0.001
Unavailable p = 0.577 p = 0.062* p = 0.063
Total omissions p = 0.003 p < 0.001 p < 0.001
* The total number used here was too large to use a Fischer’s exact test, a Chi-square with 
Yates correction was used instead.
A comparison of the three wards on how much the number of omissions in each reason 
made out  of  total  doses available  for  administrating,  several  differences was found. 
Between ward 14 and ward 16 following reasons were significant different:  IV access 
unavailable, unable to swallow and number of total omissions.  Comparing ward 16 and 
ward 6 showed significant differences in all reasons except from absent from ward and 
unavailable  medicine.  The  last  comparison  between  ward  14  and  ward  6  shows 
significant differences in the reasons  fasting patient, unable to swallow, withheld  and 
total omissions. 
The three tables below show the 5 most omitted medicines on the wards. For all three 
wards lactulose was omitted the most, at ward 14 there were 81 doses missed of this 
laxative.  Paracetamol,  senna  and  different  inhalation  preparations  against  chronic 
obstructive  pulmonary disease (COPD) and asthma were  the other  medicines most 
commonly not given to the patients. A major part of these doses were refused by the 
patients. 
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Table 6 Count of most omitted doses of medicines at ward 14 
Omitted medicine Total number of 
omitted doses
1 Lactulose oral solution 81
2 Paracetamol 33
3 Ipratropium bromide 20
4 Salbutamol 18
5 Metochlopramide 18
Table 7 Count of omitted doses of medicines at ward 16
Omitted medicine Total number of 
omitted doses





Table 8 Count of omitted doses of medicines at ward 6
Omitted medicine Total number of 
omitted doses
1 Lactulose oral solution 36
2 Movichol sachets 23
3 Senna 17
4 Paracetamol 16
5 Ipratropium bromide 14
5 Sodium chloride 14
4.4 Omissions recorded as “Unavailable medicine”
Because  patients  with  a  medicine  charted  as  unavailable  medicine  was  the  only 
category the researcher was going to include in the study, there was a need to collect 
data in more than two weeks, to have more patients to include in the study. On each of 
the three wards a period of three weeks data collection were carried out. 
Count of doses recorded as unavailable and explanations on each of these doses are 
presented in tables which can be seen in Appendix 7.
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On ward 14 36 out of 99 doses (33.4%) were written as unavailable, when the item was 
on the ward; 33 in ward cupboard/fridge and 3 in patients bed side locker.  In addition to 
this in 26 out of 99 cases (26.3 %) the medicines were not on ward, but not ordered 
before the technician came up in the afternoon. In most of these cases the morning 
dose (7.00 am) were charted as unavailable. Often seen on ward 14 was that some 
doses are charted as unavailable in the morning, not ordered by nurse and then charted 
unavailable again at 13 pm. When first charted as unavailable it can not be changed 
back, but the nurses could still give the medicine outside of this. 
In  total  for  ward,  there were  14 99 doses charted as unavailable  distributed on 66 
different medicines. Out  of  these 66 medicines 16 were stock items;  item the ward 
always have on ward. A pharmacy technician tops up the ward cupboard twice a week 
to ensure there always are enough of these medicines
In 3 doses (3.0 %) the items unavailable were non-stock items and therefore not on 
ward, but alternatives that were stock item could have been given. 
In one case at ward 14 a patient had 7 of the 14 regular medicines omitted with the 
charted reason “Unavailable medicine”. 5 of these medicines were stock items, which 
tell that the medicines should be on the ward. It was confirmed by a technician on ward 
that the medicines actually were there. 
At ward 16,  there were  35.8 % of medicines charted as unavailable were actually on 
ward.  Since  there  isn’t  a  pharmacy  technician  on  this  ward  daily,  the  unavailable 
medicines  were  checked  from  pharmacy/dispensary  with  help  from  a  pharmacy 
technician.  By using the patients hospital number there was checked when a supply 
was sent to the ward last time, and identified if the medicine were on ward or not. 
At ward 16 all patients’ medicines, both PRN medicines and other medicines are kept in 
the medicine trolleys and the researcher didn’t have access to these ones. In 15 % of 
the cases the patients were admitted in the evening after pharmacy had closed, new 
medicines were prescribed and these were non-stock items and not on ward. A print 
over new patients arrived the night before is printed 3 times daily, with list over new 
non-stock items prescribed. A list over all drugs for the patients is printed out, checked 
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for non stock or stock items, and necessary medicines are supplied to ward via porter or 
tube system. 
It was found that 7 out of 47 (14.9 %) different medicines omitted were stock items on 
ward 16. 
At the cardiology ward, station 6, 40.2 % of all medicines charted as unavailable was 
actually on the ward. In 12 % of the cases the patient was admitted in the evening and 
the prescribed medicines were non-stock items not on ward. 
Table 10 shows how many of the medicines written as unavailable that actually was on 
the ward. Table 11 compares the three settings to find out if any ward is significant 
different from one of the others when looking at how many medicines that was on the 
ward, but still charted as unavailable. 







Medicines on ward 36 (36.3) 24 (35.8) 33 (40.2)
Medicines not on ward 63 (63.6) 43 (64.2) 49 (59.8)
Total 99 (100.0) 67 (100.0) 82 (100.0)
Table 11 Comparison of ward settings using Fischer’s exact test
Ward 14/ ward 16 Ward 16/ward 6 Ward 14/ward 6
Medicines charted as 
unavailable but found 
on ward
p = 1.000 p = 0.614 p = 0.645
No significant difference was found between the wards when comparing the number of 
unavailable medicines that actually were on the ward.   
The tables below show the number of unavailable medicines in weekends for each ward 
and  a  comparison  of  the  different  settings.  The  table  shows  that  there  were  no 
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differences  in  the  number  of  unavailable  medicines  in  the  weekends  between  the 
wards. 
 
Table 11  Distribution  of  unavailable  in  weekend  and  weekdays  (total  number  of 
unavailable doses n= 248)
Ward 14 Ward 16 Ward 6
Count (%) Count (%) Count (%)
Unavailable in weekend 17 (17.1) 13 (19.4) 14 (17.1)
Unavailable in weekdays 82 (82.8) 54 (80.6) 68 (82.9)
Total 99 (100.0) 67 (100.0) 82 (100.0)
Table 12 Comparison of three wards 
Ward 14/ward 16 Ward 16/ ward 6 Ward 14/ward 6
p-value p-value p-value
Unavailable in weekends
Unavailable in weekdays p = 0.837 p = 0.831 p = 1.000
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4.5 Inclusion of patients
Number of included patients is shown in the following figure (Figure 4)
Medical cardiology ward Geriatric ward
Inclusion period 1 :16.03.09 -29.03.09
Inclusion period 2: 14.04.09-20.04.09
Inclusion period 1: 09.02.09-23.02.09
Inclusion period 2: 14.04.09-20.04.09
Total number of patients with 
“Unavailable Medicine” : 31
Total number of patients with 
“Unavailable Medicine” : 26




Number of patients not included: 15
Unable: 12
Discharged: 3
Total number of included patients:
13
Total number of included patients:
10
General medical ward
Inclusion period 1: 27.01.09 -09.02.09
Inclusion period 2: 14.04.09-20.04.09
Total number of patients with 
“Unavailable Medicine”: 39
Number of patients not included: 25
Unable: 20
Discharged: 5
Total number of included patients
14
Included patients in total for all three 
wards : 37*
Figure 4 Patients included in study
* Two of the 37 patients were admitted two times during the period therefore used as 
different cases. In total this gave 39 patient cases to present to the expert group. 
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Two inclusion periods on each ward were needed to get a suitable number of patients 
to present for the expert group. The researcher only managed to include 25 patients in 
the first inclusion period.  46 % of the patients that had an “Unavailable Medicine” were 
not able to speak to the researcher because of a serious condition such as stroke etc. 
At the geriatric ward many patients were too confused to speak to. A chief nurse or 
pharmacist on the ward was always asked if the patients were suitable to talk to the 
researcher and sign the consent form. 
13 patients were discharged before the researcher got the chance to speak to them. If a 
patient had a medicine charted as unavailable in the evening, this wasn’t recorded until 
the  next  day  and  often  these  patients  got  discharged  in  the  morning  before  the 
researcher went up to the ward. 
There was a quite even distribution  of gender in the included patients,  with  40.5 % 
females, see table 10. The mean age (SD) among the females were 72.1 years (12.4) 
and mean age (SD) among the included males were 73.3 (8.3). The mean age of all 
patients included was 72.8.
Table 14  Patients included in the study (n=37)
Number of 
patients




Female 15 40.5 % 72.1
(12.4)
Male 22 59.5 % 73.3 
(8.3)
TOTAL 37 100 % 72.8
(10.0)
  
The  most  common  presenting  complaints  among  the  patients from  all  three  ward 
settings were shortness of breath, weakness, feeling unwell and chest pain, see table 
11. Most of the patients included in the study had several symptoms when admitted to 
the hospital. The most common chronic medical conditions of the included patients were 
chronic obstructive pulmonary disease (COPD) and cerebrovascular accident. 
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Table 15 Present complaints for the 37 included patients (39 cases)
Present complaints Counts Prevalence
Shortness of breath 16 41 %
Weakness/numbness 9 23 %
Feeling unwell 6 15 %
Chest pain 4 10 %
4.6 Clinical significance of omitted doses
The expert group evaluated 74 dosing omissions distributed on 39 patient cases. Most 
of the patients only had one omitted medicine but some of the patients had several 
omitted doses and the clinical significance of each dose was evaluated separately. The 
following tables show number of doses in each category and how they were distributed 
on each ward. An example of a patient case could be seen in Appendix 8.
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Table 16: Number of omitted doses under each category of clinical significance (n= 74).  
0


















Gastro-intestinal system - 4 1 -
Cardiovascular system 1 11 - -
Respiratory system - 12 - -
Central nervous system - 8 - -
Infections 1 - 2 1
Endocrine system - 3 7 -
Obstetric, gynaecology and 
urinary tract disorders 1 2 - -
Malignant disease and 
immunosuppression - - 1 -
Nutrition and blood - 2 7 -
Musculoskeletal and joint diseases - 2 - -
Eye - 2 - -
Ear, nose and oropharynx - - - -
Skin 1 2 2 -
Immunological products and 
vaccines
- - - -
Anaesthesia - - - -











Table 17 Clinical significance distributed on the three wards
0

















Ward 14 21 7 1
Ward 16 4 14
Ward 6 13 14
TOTAL 4 48 21 1
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Most of  the omitted doses were medicines in  the BNF category cardiovascular and 
respiratory  system.  In  these  categories  the  omitted  doses  were  evaluated  to  be  in 
category 1 except from two drugs which was evaluated to category 0. 
Most of the omitted doses under the category gastrointestinal system were proton pump 
inhibitors and all of them were categorized in number 1 with one exception; one patient 
missed a dose of esomeprazole and this omission was evaluated to have a clinical 
significance in category 2; Major disturbance of symptom control. The explanation is 
that the patient was admitted with abdominal pain. 
In  three of  the cases presented for  the expert  group an antibacterial  drug was  the 
omitted  drug.  Two of  them were  evaluated  to  be  in  category  2.  The  last  one was 
evaluated to be in category 3. In this case a patient missed two doses of doxycycline 
(the  first  and  second  dose).The  medicine  was  prescribed  for  use  once  daily,  and 
missing  two  doses of  this  antibiotic  was  therefore evaluated to  be a major  treat  to 
stability of patient’s condition.
Among the omitted medicines in the endocrine system there were category 1 and 2. In 
one case an immunosuppressive drug was omitted. This omission was categorized as a 
2: Major disturbance to symptom control. In addition to this medicine (Azathiorpine) the 
patient was on steroids. Azathiorpine is a steroid sparing drug, and missing this dose 
gives less control over steroid levels. 
4.7 Guidelines
The  following  table  show the  guideline  developed  after  meeting  with  expert  group. 
Medicines missions categorised as a category 2 or 3 was included as basis for the 
guidelines. 
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Table 18 Medicines that should not be omitted
Medicines Example
Antibiotics 
- Especially first doses (Dose 1-4) are very 





Different cures with a specific number of days 
treatment
- It is important for patients to have all doses 
in such cures
Clotrimazole (3 days cure)




5.1.1 Recorded reasons for dose omissions 
When deciding what reasons to record, several reasons for charting a medicine as not 
given was not included. Examples here are reasons where the doctors had decided to 
withhold, withdraw or discontinue a medicine of any reason. The researcher didn’t think 
of these ones as omitted medicines, since there normally are medical reasons for these 
decisions. If all reasons for not giving a medicine have been included, the numbers of 
omissions would have been higher.  
The following reasons; Refused, IV access unavailable, unavailable medicine, unable to  
swallow, absent from ward and fasting patient are all thought to be preventable dosing 
omissions, and were therefore recorded in the study.
5.1.2 Results from data collection 
Of all  the reasons recorded in the 2 weeks of data collection,  refused  was the most 
common and laxatives were seen as the most common medicines that the patients 
refused  to  take.  The  patients  can  decide  themselves  which  medicines  to  take  and 
refusing to take a medicine turned out to be more common than expected. Refused 
medicines was often laxatives or painkillers; these are medicines that the patients can 
decide themselves whether they need or not. This could indicate that the prescriber not 
is prescribing appropriately since laxatives and painkillers are often best prescribed as 
PRN medicine. 
In the cases where important medicines are refused by patients it is of importance that 
both  patients  and  nurses  get  information  about  the  importance  of  taking  such 
medicines.  
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The results of this study suggest that nurses sometimes write the wrong reason for not 
administrate a medicine. In one case a patient got 7 out of 14 regular drugs omitted 
because of  “Unavailable  medicine”.  Questions can be asked if  this  was the correct 
reason  to  chart  since  several  of  the  omitted  medicines  were  stock  items,  and  the 
pharmacy technician on ward said that these were in the ward cupboard. It’s therefore a 
possibility  that the medicines were on the ward but not found by the nurse, or  that 
wrong reason was charted. The rest of the medicines the patient should have been 
taken were charted as ‘Unable to swallow’,  and it  could have been this reason that 
should have been charted.
Several  other  examples could indicate that  the nurses sometimes chose the wrong 
reason; in one case it was charted that the patient didn’t have a medicine because the 
patient was absent from ward. It is likely to believe that this reason was wrong since the 
patient  got  all  other  medicines  that  should  have  been  administered  at  the  same 
administration time.  
5.1.3 Inclusion of patients
It was experienced a difficulty to include patients in the study. To summarize the clinical 
context  on the patients  the researcher  needed to  get  information by reading in  the 
patients’  medical  notes.  Because  the  researcher  not  was  a  part  of  the  patient’s 
treatment group, consent from each patient was needed before any information about 
the patient could be used. This turned out to be quite a challenge. 
In total in all three wards 46 % of the patients that had an unavailable medicine, and 
therefore should have been included in the study, were unable to sign the consent from 
because of serious illness or dementia. Ward 16 is a geriatric ward and a major part of 
the patients have dementia or are too confused to speak to, and ward 14 had a lot of 
very sick patients. This resulted in only 37 included patients in total (14 from ward 14, 
13 from ward 6 and 10 from ward 16).
If consent from the patients not was needed, all patients with an unavailable medicine 
could have been included and the numbers would be more correct. 
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A lot of the time during the collection period was used to write down every omission for 
every patient. Every patient needed to be checked separately, and this was quite time 
demanding. 
5.2 Comparison of the three wards
In results the per cent of dosing omissions within each reason was calculated from total 
omitted  doses  during  the  collection  period  and  from  total  medicines  available  for 
charting. The numbers calculated from total omitted doses don’t say that much about 
the frequency of each reason. The number calculated from total omitted doses only tells 
how  often  a  reason  occur  compared  with  the  other  reasons,  while  the  number 
calculated from total doses available for charting says something about the frequency 
per prescribed dose. 
One example could be if the number of  unavailable  is 20 in one week and the total 
number of omissions is 100. Unavailable then make 20 per cent of total omissions. 
In another ward the number of  unavailable could also be 20, but if the total number 
omissions is 200, this reason will only make 10 per cent of total omissions. This could 
give a wrong impression because if these percentages are compared, it looks like one 
ward has more unavailable than the other. When frequency of unavailable should be 
compared within wards, the numbers will  be more informative if calculated from total 
doses prescribed at each ward. 
When the wards were compared several  differences were found. In the numbers of 
unable to swallow, all  wards were significant different from each other. As shown in 
frequency tables,  ward  6  was  the  ward  with  fewer  medicines  written  as  unable  to 
swallow.  This could be explained by the types of patients in the different wards; ward 
14 has a lot of very sick patients and due to these difficulties in swallowing medicines 
can occur. Ward 16 is a geriatric ward and for elderly people it is also quite common to 
have difficulties  with  swallowing medicines.  To  avoid that  this  is  becoming a major 
problem, a suggestion would be that the wards should have more suspensions and 
mixtures as replacement for tablets and capsules. 
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The numbers  from some other  reasons were  also  shown to  be  significant  different 
between the wards, such as withheld and IV access unavailable, but it is difficult to think 
of a reason why this occur more in one ward than another. 
5.3 Unavailable medicines
The three wards have different systems to supply medicines to the ward and before the 
study started it was suggested that the system on ward 16 should be the best one. As 
explained in the introduction this system is based on lists printed three times daily over 
new non-stock items prescribed. The nurses do not need to order it; a new medicine 
prescribed will show on the list and than supplied to the ward. Compared to the results 
from  the  first  4  week  before  the  pilot  the  number  of  unavailable  medicines  has 
decreased. In total for these 4 weeks 143 medicines were charted as unavailable, in 
this study; 67 on three weeks.  In the last week of the pilot there were 21 missed doses 
and this number is not that different from the one found in this study (in average 22.3 
doses each week.) 
Ward 14 has the redesign system, it was thought that using patient own drugs and one 
stop dispensing was going to keep number of unavailable medicines down. The system 
includes that a pharmacy technician is up on the ward every day ordering all needed 
medicines. If the technician not is there, the nurses could order any needed medicines 
themselves. In the study it was experienced that the nurses often charted medicines as 
unavailable in the morning instead of order the medicine from pharmacy and give it to 
the patient with a couple of hours delay. 
Often seen on this ward was that nurses were charting medicines as unavailable in 
morning, and again at 13.00 pm. This was noticed by the technician when he/she came 
up on the ward in the afternoon, and not ordered until  then; this could cause many 
hours delay for the patient, and possible two or three missed doses. In 26 of 99 doses 
(26,3 %) the medicines were not on ward, but could have been ordered from pharmacy 
in the morning instead of waiting for technician to come up in the afternoon.
If the pharmacy is closed when a medicine not on ward is needed, the theory says that 
a call  around to other wards to check if someone has the medicine is necessary.  In 
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addition there is an emergency cupboard which includes most medicines, this should 
also be checked. If  the medicines can not be found either in ward cupboard or the 
emergency cupboard, an on-call pharmacist should be called to find out if the medicine 
is really important to take or not. This study gives a reason to believe that this is not 
done every time a medicine is unavailable. Even though this doesn’t happen all  the 
time, there is a need to explain to the nurses the importance of giving single doses, and 
that they shouldn’t be omitted.  
A comparison of the three wards didn’t  show any  significant difference between the 
wards in number of unavailable medicines. The study therefore suggests that neither of 
the supply systems is different from another, but to be more conclusive here more and 
longer studies need to be carried out. But some theories can be made out from this 
study. 
The  redesign  system  includes  more  staff  on  ward,  with  technicians  ordering  all 
medicines for patients. It could seem like the nurses not are ordering needed medicines 
when they know that a technician comes up to the ward and takes care of the ordering 
in the afternoon. 
Because  it  looks  like  the  nurses  often  are  charting  wrong  reasons,  not  order  all 
medicines when needed and too often write a medicine as unavailable when the item is 
on ward,  there could be a need for  more information to nursing staff  in addition to 
review the different supply systems, to avoid unavailable medicines.  
5.4 Clinical significance 
An omitted dose for the patients not included would probably be of a higher clinical 
significance than the healthier patients that the researcher got consent from. If a patient 
has a serious condition, it is often more important to have all medicines, and therefore 
an omission could cause more harm to this patient than if a healthier patient had the 
same medicine omitted. 
After the expert group had evaluated the dosing omissions,  the results were used to 
develop guidelines for nursing staff over medicines that should not be omitted. Since 
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the guidelines were developed only from omitted medicines for patients who gave their 
consent,  several  medicines  were  not  included.  In  addition,  not  all  the  different 
categories in the BNF system was represented, and some of these categories could 
include  medicines  of  big  importance  to  patients.  This  guideline  is  therefore  not 
appropriate to use before more studies have been done on the same field. Still it gives a 
good indication of what medicines are most important to give to patients. 
5.5 Expert group
The expert group consisted of 4 pharmacists. All cases were discussed within the group 
and a common decision was made about clinical significance of the dosing omissions. 
For evaluation of the clinical importance it was planned to include a doctor but this was 
not  done  because  the  doctors  didn’t  have  time.  There  is  likely  to  think  that  some 
difference in the categorisation would arise if a doctor were a part of the discussion. If a 
similar study is going to be done later, there could be interesting to include a doctor for 
different  opinions  and  in  addition;  the  expert  group  could  evaluate  individually  the 
clinical significance is and eventually different opinions could have been written down 
and  discussed  if  necessary.  Some  difference  in  opinions  would  probably  appear  if 
members of the expert group decide individually without discussing with the others first. 
A short comparison of the results from the expert group with the other researcher EJ, 
showed that some cases were evaluated different. In some cases were the same drugs 
were  omitted  and  patients  had  quite  similar  medical  history,  different  evaluation  of 
clinical significance was made. A limitation with this group could therefore be different 
opinions of the pharmacists
5.6 Limitations with the study
One of this study’s  limitations is that there was not any assessment of  the charted 
reasons. The nurses were not aware of the study, so that they could not have a change 
to  improve  anything.  Therefore  it  was  difficult  to  check  if  the  right  reasons  for  not 
administrate a drug was written down.
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There were not done any direct observations of nurses administrating drugs to patients 
but this could have detected more specific errors than this study does. Several studies 
done on the same area, omitted medicines in hospital,  have used different methods 
than the researcher, such as following the nurse around for 24 hours to find out which 
doses are omitted and what the actual reasons for not administrate a medicines is (not 
only the charted reasons). Direct observations would have given more correct numbers.
In  the  study “Audit  of  dose  omission  and  completed  drug  allergy  status”  by  Dhruti 
Bhatt12 it was found that 37 % of all doses were omitted. In this project the ward with the 
highest percentage was ward 16 with 9.8 % missed doses in total. There is a limitation 
by compare this study with other studies since the methods are different. Although the 
numbers found in this study seems to be quite low there is room for improvement in all 
three wards. 
During the last two weeks of data collection at ward 6 a pilot of system was tried out. 
Based on the computer system every new non-stock item prescribed is printed on a list 
three times daily. In addition all new patient admitted from last report is on the same list, 
and all needed medicines for these patients are supplied to the ward. These changes 
could have given less unavailable medicines and this data then differ from the first week 
when these changes were not implemented yet.  
One other limitation is the weekends. The numbers of omitted doses from weekends are 
not quite correct because patients get discharged and new patients arrive during 
weekends. A patient could possibly be admitted Friday night and miss some doses, but 
be discharged before the researcher came back on Monday. Some omissions would 
therefore be missed by researcher and not give the exact numbers. 
This study of medicines written as unavailable was carried out only for 3 weeks. More 
data collection should have been done to say anything about the differences in the 




Omissions of medicine doses do not always cause any disturbance of symptom control 
or potential harm for the patients. But in some cases omitted doses could lead to harm 
such  as  omitting  antibiotics  or  glucocorticoids.  The  guidelines  developed  after 
assessment of  clinical  significance of dose omissions is not sufficient to use before 
more  medicines  are  included.  Still  the  guideline  gives  a  good  indication  of  what 
medicines that it is important not to miss.   
 
To  ensure that  medicines are available  all  the  time,  a  review of  supply  systems is 
needed. In addition this study suggests the nurses should get more information about 
medicines  the  patients  cannot  miss,  because  a  lot  of  the  medicines  charted  as 
unavailable were still found on ward. 
In  this  study no significant  difference between the numbers of  medicines written  as 
unavailable in the three medicines management systems was found. More studies on 
this need to be done to be more conclusive in what changes need to be done in the 
systems.  
In this study it  was not done any direct  observation when the nurses administrated 
medicines. No assessment of the charted reasons was done so it is not possible to say 
if  the  charted  reasons  were  the  correct  ones.  To  avoid  this  in  a  similar  study  the 




Appendix 1 Template for recording all dose omissions
Data collection – Dose omissions                             
Station: 
Date:
Number of patients on ward: 
Reasons for dose omission
Medicine (name, 


















Appendix 2 Template for patient summary









Name of medicine Dose Frequency
Dose omissions (recorded as “Unavailable Medicine”)
Date Time Medicine omitted Actual reason for omission
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Appendix 3 Consent form
CONSENT FORM
The study of Doses of Medicines not given in Surgical and 
Medical Patients in the Ayr Hospital
Name of Researchers:  Elisabeth Johansen and Kristin Reinaas Lysheim
         Please initial box
1. I confirm that I have read and understand the information sheet dated
12/12/2008 for the above study. I have had the opportunity
 to consider the information, ask questions and have had these answered
satisfactorily.
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without any medical care or legal 
rights being affected.
3. I understand that relevant sections of any of my medical notes and data 
collected during the study, may be looked at by responsible individuals 
from Ayr Hospital pharmacy department. I give permission for these
   individuals to have access to my records.
4.   I agree to take part in the above study.
________________________ ________________ ___________________
Name of Patient Date Signature
_________________________ ________________ ___________________
Name of Person taking consent Date Signature




When completed,  1 for patient;  1 for researcher site file;  1 (original) to be kept in medical notes
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Appendix 4 Patient information sheet
PATIENT INFORMATION SHEET
The study of Doses of Medicines not given in Surgical and Medical 
Patients in the Ayr Hospital
You are being invited to take part in a research study.  Before you decide it is important 
for you to understand why the research is being done and what it will involve.  Please 
take time to read the following information carefully. Talk to others about the study if you 
wish. 
Ask us if there is anything that is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part.
What is the purpose of the study?
Sometimes doses are missed in medicines that have been prescribed. There can be lot 
of reasons for this to happen. The aim of this study is to find out the reasons why this 
happens and to try to prevent it happening in the future. 
Two final year pharmacy university students from Norway who are currently working 
with the pharmacists in Ayr Hospital and Strathclyde University will carry out the study. 
The students’ names are Elisabeth Johansen and Kristin Reinaas Lysheim.
Why have I been chosen?
You have been chosen because you have been admitted to the wards that the study is 
taking place, which are Stations 6, 10, 12, 14, 16 during the study time period.
It is hoped we will study a total of about 200 patients during the time period.
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Do I have to take part?
No.  It is up to you to decide whether or not to take part.  If you do, you will be given this 
information sheet to keep and be asked to sign a consent form. You are still free to with-
draw at any time and without giving a reason.  
A decision to withdraw at any time, or a decision not to take part, will  not affect the 
standard of care you receive. 
What will happen to me if I take part?
If you decide to take part in this study, your notes and the electronic prescribing system 
will be accessed when you in hospital.  The electronic prescribing system also contains 
the information about which medicines you have received and which ones you have not 
received. This information will be used by the students in the research. 
Any information taken from your notes will be kept anonymous. 
What do I have to do?
You are only required to give permission for the information in your notes to be used as 
part of the study.
You will not have to do anything, complete any forms or visit any clinics or hospitals 
during the study. 
If you decide to take part in the study, you will be asked to sign a consent form. This will 
allow us to access your notes when you are in hospital and use the information in your 
notes. 
After this you will not be asked to do anything else.
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What are the possible benefits of taking part?
There are no direct benefits to your treatment by taking part in the study. 
However, if the study produces good results it will give us information on how to prevent 
doses being missed in the future.
This may benefit patients in Ayrshire and Arran in the future.
What if there is a problem?
Any complaint about the way you have been dealt with during the study will be 
addressed. 









If you remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure. Details can be obtained from Ayr Hospital.
Will my taking part in the study be kept confidential? 
Yes.  All the information about your participation in this study will be kept confidential.  
You will be given a copy of the information sheet and a signed consent form to 
keep.
Thank you for taking time to read the information sheet and for considering taking part 
in this study
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4. Central nervous system
5. Infections
6. Endocrine system
7. Obstetrics, gynaecology, and urinary-tract disorders
8. Malignant disease and immunosuppression
9. Nutrition and blood
10.Musculoskeletal and joint diseases
11.Eye
12.Ear, nose and oropharynx
13.Skin
14. Immunological products and vaccines
15.Anaesthesia
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Appendix 7: Actual reasons for medicines recorded as unavailable
A  Item on ward 
B  Item not on ward 
Ward 14
Actual reason for medicine 
recorded as unavailable
Count of doses
A1 Item in ward cupboard/fridge 33
A2 Item in patient bedside 
locker
3
B1 Item not on ward 24
B2 Item not on ward, alternative 
route/strength could have been 
used
3
B3 Item not on ward, could have 
been ordered by nurse instead 
of waiting for technician
4
B4 Patient admitted after 
pharmacy had closed (evenings 
or weekends
10
B5 Not on ward - could have 




Actual reason for medicine 
recorded as unavailable
Count of doses
A1 Item in ward cupboard/fridge 24
B1 Item not on ward 31
B2 Another route /strength could 
have been used
1
B3 Could have waited 1
B4 Item not on ward – new 




Actual reason for medicine 
recorded as unavailable
Count of doses
A1 Item in ward cupboard/fridge 33
B1 Item not on ward 27
B2 Item not on ward, alternative 
route/strength could have been 
used
0
B3Patient admitted after 
pharmacy had closed (evenings 
or weekends
1
B4Not on ward – could have 








- Severe COPD                   - Hiatus hernia
- Osteoporosis                    - Transurethral resection of the prostate(TURP)




- SOB (Shortness of breath)
Current drugs:
Name of medicine Dose Frequency
Dalteparin 5000 units OD
Ipratropium bromide 500µg 500 µg Four times daily
Lansoprazole 30 mg 30 mg OD
Prednisolone 5 mg 30 mg OD
Zafirlukast 20 mg 20 mg BD at 7am, 10 pm
Sodium chloride 0,9 % 1 nebule(s) Four times daily
Terbutaline 5 mg in 2 ml 5 mg Four times daily
Ciprofloxacin 500 mg 500 mg BD (stopped march 16.)
Bumetanide 1 mg 1 mg OD
Theophylline 200 mg 200 mg OD at 10 pm
Solifenacin 5 mg 5 mg OD
Theophylline 300 mg 300 mg OD
Ramipril 5 mg 5 mg OD
Clarithromycin 250 mg 500 mg BD
Aledronic acid 70 mg 70 mg Once weekly
Seretide 500 Accuhaler 2 blister(s) BD
Dose omissions (recorded as “Unavailable Medicine”)
Date Time Medicine omitted Clinical significance
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